David Colleran - Mar 10, 2023 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role: EVP, General Counsel, Corp Sec
Signature: /s/ David Colleran
Stock symbol: ANIK
Transactions as of: Mar 10, 2023
Transactions value $: -$58,725
Form type: 4
Date filed: 3/14/2023, 04:46 PM
Previous filing: Mar 10, 2023
Next filing: Mar 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANIK	Common Stock	Options Exercise	$0	+7.66K	+51.52%	$0.00	22.5K	Mar 10, 2023	Direct	F1
transaction	ANIK	Common Stock	Tax liability	-$58.7K	-2.25K	-9.98%	$26.10	20.3K	Mar 10, 2023	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANIK	Restricted Stock Unit	Options Exercise	$0	-7.66K	-33.33%	$0.00	15.3K	Mar 10, 2023	Common Stock	7.66K	$0.00	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the first vesting installment of Restricted Stock Units (RSUs) granted on March 11, 2022.
F2	Reflects an aggregate of 2,250 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2023.
F3	Reflects the closing price of ANIK common stock on March 10, 2023, the trading day immediately preceding the date on which the vesting of RSUs gave rise to tax withholding obligations.
F4	Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023.